$3.96
+8.6%Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
CLOV โข NASDAQ
| Clover Health Investments, Corp. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
1.9B | 1.4B | 1.3B | 1.1B | 1.5B | 672.9M | 462.3M | 281M | |
GROSS PROFIT | ||||||||
(1.6B) | (1B) | (1B) | (993.1M) | (1.6B) | (590.1M) | (449.7M) | (0.0) | |
355.9M | 364.8M | 256M | 103.5M | -79.2M | 82.8M | 12.6M | 281M | |
OPERATING INCOME | ||||||||
(441.4M) | (410.6M) | (461.3M) | (390.1M) | (557.8M) | (175.5M) | (195.8M) | (476M) | |
(176.3M) | (408.9M) | (440.2M) | (482.4M) | (445.7M) | (192.1M) | (187.3M) | (187.3M) | |
-85.5M | -45.7M | -205.3M | -286.7M | -637M | -92.7M | -183.2M | -185.8M | |
PRE-TAX INCOME | ||||||||
(0.0) | (0.0) | (7K) | (1.4M) | (16.9M) | (57.1M) | (39.1M) | (0.0) | |
0.0 | 0.0 | -7K | -1.4M | -16.9M | -57.1M | -39.1M | 0.0 | |
(265.1M) | (1.6M) | (21M) | -92.3M | (112.1M) | -16.6M | (8.4M) | (0.0) | |
-20K | -517K | -4.8M | 32.1M | 49.2M | -43.7M | -180.5M | -16.1M | |
-85.5M | -46.3M | -210.1M | -254.6M | -587.8M | -136.4M | -363.7M | -201.9M | |
NET INCOME | ||||||||
-85.5M | -43M | -213.4M | -339.6M | -587.8M | -136.4M | -363.7M | -201.9M |
CLOV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 18, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 30, 2026 | 2026 | |
8-K/A 8-K/A 2026 (Amended) N/A | March 06, 2026 | March 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 06, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 14, 2026 | January 14, 2026 | 2026 |
Continue your CLOV research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.